右羟吗喃结构式
|
常用名 | 右羟吗喃 | 英文名 | DEXTRORPHAN D-TARTRATE |
---|---|---|---|---|
CAS号 | 125-73-5 | 分子量 | 407.45700 | |
密度 | 1.17g/cm3 | 沸点 | 410.4ºC at 760mmHg | |
分子式 | C21H29NO7 | 熔点 | ≥195ºC | |
MSDS | 中文版 美版 | 闪点 | 207.2ºC | |
符号 |
GHS07 |
信号词 | Warning |
中文名 | 右羟吗喃 |
---|---|
英文名 | dextrorphan |
中文别名 | 右啡烷 | 右美沙芬杂质B |
英文别名 | 更多 |
密度 | 1.17g/cm3 |
---|---|
沸点 | 410.4ºC at 760mmHg |
熔点 | ≥195ºC |
分子式 | C21H29NO7 |
分子量 | 407.45700 |
闪点 | 207.2ºC |
精确质量 | 407.19400 |
PSA | 138.53000 |
LogP | 0.89570 |
蒸汽压 | 0mmHg at 25°C |
折射率 | 1.621 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:5 3.氢键受体数量:8 4.可旋转化学键数量:3 5.互变异构体数量:3 6.拓扑分子极性表面积139 7.重原子数量:29 8.表面电荷:0 9.复杂度:491 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:5 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2 |
更多 | 1.性状:白色类白色结晶。 2.熔点(℃):≥195。 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | 22 |
危险品运输编码 | NONH for all modes of transport |
RTECS号 | QD1832000 |
右羟吗喃上游产品 0 | |
---|---|
右羟吗喃下游产品 1 | |
Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device.
Xenobiotica 45(1) , 29-44, (2014) 1. The quantitative prediction of the pharmacokinetic parameters of a drug from data obtained using human in vitro systems remains a significant challenge i.e. prediction of metabolic clearance in hum... |
|
Evaluation of thein vitro/in vivodrug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition
Food Chem. Toxicol. 68 , 117-27, (2014) • BST204 is a purified dry extract of ginseng containing high amounts of Rh2 and Rg3. • BST204 had only weak inhibitory effects on nine CYPs and five UGTs. • It is unlikely that BST204 alter pharmacok... |
|
Determination of sitafloxacin in human plasma by liquid chromatography–tandem mass spectrometry method: Application to a pharmacokinetic study
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 957 , 36-40, (2014) • An LC–MS/MS method has been developed for determining sitafloxacin in human plasma. • The method has some merits: high sensitivity, small sample volume and short runtime. • It is successfully applie... |
(+)-3-hydroxy-N-methylmorphinan |
Dextro-Dromoran |
D-3-hydroxy-N-methylmorphinan |
DEXTRORPHAN D-TARTRATE |
MFCD00864199 |
d-Form of levorphanol |
O-Demethyl dextromethorphan |
d-Levorphanol |
(+)-N-Methylmorphinan-3-ol |
Racemorphan |
EINECS 204-754-3 |
Dextrorphane |